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Alternative oxidases (AOXs) bypass respiratory
complexes III and IV by transferring electrons from
coenzyme Q directly to O2. They have therefore
been proposed as a potential therapeutic tool for
mitochondrial diseases. We crossed the severely
myopathic skeletal muscle-specific COX15 knockout
(KO) mouse with an AOX-transgenic mouse. Surpris-
ingly, the double KO-AOX mutants had decreased
lifespan and a substantial worsening of themyopathy
compared with KO alone. Decreased ROS produc-
tion in KO-AOX versus KO mice led to impaired
AMPK/PGC-1a signaling and PAX7/MYOD-depen-
dent muscle regeneration, blunting compensatory
responses. Importantly, the antioxidant N-acetylcys-
teine had a similar effect, decreasing the lifespan of
KOmice. Our findings havemajor implications for un-
derstanding pathogenic mechanisms in mitochon-
drial diseases and for the design of therapies, high-
lighting the benefits of ROS signaling and the
potential hazards of antioxidant treatment.
INTRODUCTION
Oxidative phosphorylation (OXPHOS) is the process by which
mitochondria convert the energy derived from nutrients into
ATP. Electrons generated by intermediary metabolism in the
form of reducing equivalents are transferred along the four com-
plexes of the mitochondrial respiratory chain (complexes I–IV,
cI–cIV) to eventually combine with molecular oxygen to produce
water. This exergonic process, termed respiration, sustains the
extrusion of protons across the inner mitochondrial membrane,
carried out by proton pumps present in cI, cIII, and cIV. Proton
translocation generates an electrochemical gradient, giving
rise to a membrane potential, Dj, which is exploited by the
ATP synthase (complex V, cV) to convert ADP and Pi to ATP.
Mutations in a vast array of genes encoded by either the nuclear
or mitochondrial DNA (mtDNA) disrupt the respiratory chain and764 Cell Metabolism 28, 764–775, November 6, 2018 ª 2018 The Au
This is an open access article under the CC BY license (http://creativelead to primary mitochondrial diseases. Several interconnected
mechanisms account for the cellular consequences of OXPHOS
defects, including decreased ATP synthesis, increased produc-
tion of reactive oxygen species (ROS), altered ion trafficking,
deranged metabolite levels, and abnormalities in mitochon-
drial-related cell death and turnover pathways such as apoptosis
and autophagy.
In particular, ROS are by-products of normal respiration, but
can increase dramatically when the respiratory chain is impaired.
ROS are in fact thought to play a ‘‘hormetic’’ double role: in phys-
iological conditions, low levels of ROS act as signalingmolecules
regulating homeostatic pathways related to mitochondrial bio-
energetics, whereas at high levels they act as toxic agents
damaging cellular components, including nucleic acids, pro-
teins, and lipids (Yun and Finkel, 2014). Along the respiratory
chain, ROS are generated at different sites with cI, cII, and cIII
playing the main role (Brand, 2016). In particular, cI generates
ROS through reverse electron transfer (RET), which exploits
the electrons flowing back from coenzyme Q (CoQ) when this
is over-reduced by electrons from cII (Chouchani et al., 2014)
or in the presence of drugs or genetic defects that inhibit cIII
and/or cIV (Guara´s et al., 2016). Although the detrimental role
of ROS has recently been challenged (Scialo` et al., 2016), cells
have evolved highly efficient ROS scavenging systems, which
in mammals are mainly controlled by an antioxidant response
program, based on the Kelch-like ECH-associated protein 1
(KEAP1) and nuclear factor erythroid 2-related factor 2 (NRF2/
NFE2L2) (Holmstro¨m and Finkel, 2014).
In spite of recent progress, no specific therapy is currently
available for OXPHOS disorders. Because of their huge genetic
heterogeneity, an effective therapy should have the widest
possible applicability or at least have the potential to be applied
to more than a single disease entity.
Alternative oxidases (AOXs) are cyanide-resistant, mem-
brane-boundmitochondrial enzymes present in plants, lower eu-
karyotes, and some specific metazoan phyla, consisting of just a
single gene product. AOXs maintain electron flow when the res-
piratory chain is inhibited at the level of cIII and/or cIV, by directly
transferring electrons from CoQ to O2, thus bypassing cIII and
cIV and preventing over-reduction of the CoQ pool. Notably,
AOX activity is not associated with proton pumping across the
inner mitochondrial membrane and thus does not contributethor(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
Figure 1. AOX Expression Exacerbates the
Physical Properties and Lifespan of KOMice
(A) Total movement of male 8-week-old WT, AOX,
KO, and KO-AOX mice measured by CLAMS and
indicated as counts per night (n = 8–10).
(B) Treadmill analysis of motor performance (n = 4).
(C) Kaplan-Meier survival curves (number of ani-
mals used are WT, 17; AOX, 15; KO, 31; KO-AOX,
16; KO-NAC, 8). Mean lifespans of KO-AOX and
KO-NAC are compared with KO by one-sample t
test. N-Acetylcysteine (NAC) was given to KO mice
in the drinking water from 3 weeks of age.
Bars represent means ± SEM. Asterisks over the
bars indicate statistical significance versus WT;
over the brackets among indicated groups. *p %
0.05; **p% 0.01; ****p < 0.0001; unpaired Student’s
t test.directly to the maintenance of Dj and ATP synthesis. However,
in the presence of cIII or cIV defects, the increase in proton
pumping at cI, due to the re-activation of electron flow, should
sustain the electrochemical gradient and ATP production.
Importantly, the re-activation of electron flow by AOXs limits
the excessive generation of ROS and maintains redox homeo-
stasis, thereby maintaining tricarboxylic acid cycle activity (Mills
et al., 2016). This has been exploited extensively to improve the
phenotype of cellular and fly models with cIII and cIV defects (El-
Khoury et al., 2014). However, its use in mammalian models has
not been explored so far. Here, we report the in vivo effects of
AOX expressed in a skeletal muscle-specific knockout mouse
for Cox15 (Cox15sm/sm, hereafter designated KO), encoding the
terminal enzyme of the biosynthetic pathway of heme a, an
essential prosthetic group of cIV (cytochrome c oxidase [COX]).
RESULTS
AOX Expression Exacerbates the Phenotype of KOMice
KO mice develop a profound, muscle-restricted COX deficiency
leading to severe mitochondrial myopathy and early death (Vis-
comi et al., 2011). A mouse strain carrying AOX from the tunicate
Ciona intestinalis inserted in the murine Rosa26 locus has
recently been described (AOXtg, hereafter designated AOX),
and was shown to be phenotypically indistinguishable from
wild-type (WT) littermates (Szibor et al., 2016).
We crossed the KO and AOX lines to generate KO-AOX double
mutants, to test whether AOX could alleviate the KO phenotype.
Unexpectedly, KO-AOXmice showed amore severe phenotype,Cell Metabwith earlier onset of symptoms than KO,
characterized by decreased body weight
(Figure S1A) due to diminished fat mass
(Figure S1B) and decreased total sponta-
neous movements (Figure 1A) as well as
treadmill motor performance in compari-
son with KO littermates (Figure 1B). The
survival probability of the KO-AOX mice
was markedly lower as well; its median
lifespan was 60 days compared with
150 days for KO (log rank, p < 0.0001; Fig-
ure 1C). In fact, all the KO-AOX mice hadto be euthanized by 90 days of age because of their poor
condition.
Since the COX defect in KO mice is muscle specific, we
reasoned that worsening of the myopathy might be responsible
for the more drastic phenotype of KO-AOX mice. We thus
analyzed the skeletal muscle from 8-week-old animals of the
four genotypes, i.e., before KO-AOX mice start to die. COX/
SDH histochemical staining confirmed the expected preva-
lence of COX-deficient fibers in KO versus WT and AOX
animals. However, the defect was even more prominent in
KO-AOX samples (Figure 2A). In addition, SDH staining was
increased in KO muscles, but it was similar to the WT in KO-
AOX mice (Figures S2A and S2B). Quantitative spectrophoto-
metric assay of COX-specific activity in muscle homogenates
confirmed this observation (10.29 ± 1.46 in KO versus 4.17 ±
0.47 in KO-AOX; p < 0.01; Figure 2B). Likewise, morphological
analysis by hematoxylin and eosin (H&E) staining revealed
significantly decreased cross-sectional area of KO-AOX versus
KO myofibers (Figure 2C). The number of centralized nuclei, an
index of skeletal muscle regeneration, was markedly increased
in KO versus WT and AOX (8.55% ± 0.73% in KO versus
0.41% ± 0.13% in WT), but much less so in KO-AOX mice (Fig-
ure 2D). This finding prompted us to investigate the differentia-
tion of satellite cells in the skeletal muscle of the different geno-
types. The number of nuclei positive for PAX7, a marker of
resident myoblasts, and MYOD, a marker of the differentiating
satellite cells, was significantly increased in KO versus WT
and AOX muscles, but it was expressed at normal levels in
KO-AOX mice (Figures 3A and 3B).olism 28, 764–775, November 6, 2018 765
Figure 2. AOX Expression Worsens the
Biochemical Muscle Phenotype of KO Mice
(A) Histochemical analyses of cytochrome c oxi-
dase (COX), succinate dehydrogenase (SDH),
double staining of COX-SDH, and H&E in 8-week-
old WT, AOX, KO, and KO-AOX animals.
(B) Spectrophotometric specific activity of cIV in
skeletal muscle of 8-week-old mice (n = 5).
(C) Analysis of the cross-sectional area of muscle
fibers (n = 4).
(D) Analysis of the number of centralized nuclei in
muscle fibers (n = 4).
Bars represent mean ± SEM. Asterisks over the
bars indicate statistical significance versus WT;
over the brackets among indicated groups. *p %
0.05; **p % 0.01; ***p % 0.001; ****p < 0.0001;
unpaired Student’s t test.Next, we investigated if AOX determined a switch in the fiber
type by immunodecorating muscle sections with antibodies
against the different myosin isoforms. However, no differences
were observed (Figures S3A and S3B). Taken together, these
data clearly indicate that the mitochondrial myopathy was signif-
icantly more severe in KO-AOX animals.
Next, we confirmed AOX expression and catalytic activity in
KO-AOX individuals. Western blot immunovisualization showed
robust expression of AOX in most tissues except brain of adult
mice, as previously reported (Szibor et al., 2016) (Figure S4A).
Oxygraphic analysis of isolated mitochondria in the presence
of ADP (state III) demonstrated substantial cyanide-resistant
respiration in muscle of both AOX and double recombinant
KO-AOX mice (Figure S4B). State III O2 consumption rate was
markedly higher in WT and AOX mitochondria compared with
KO and KO-AOX. In contrast, oligomycin-sensitive respiration
was markedly increased in both AOX and KO-AOX muscle mito-
chondria compared with the corresponding naive models, WT766 Cell Metabolism 28, 764–775, November 6, 2018and KO, respectively (Figure S4C). These
results indicate that AOX-dependent
respiration is active but insensitive to
either cyanide or oligomycin inhibition.
AOX Expression Interferes with
Mitochondrial Biogenesis in
KO-AOX
In addition to SDH staining, CS activity
was also increased in KO animals
compared with controls and KO-AOX
(Figure 4A). These data prompted us to
evaluate other markers of mitochondrial
biogenesis in skeletal muscle. The mtDNA
copy number (Figure 4B) and the expres-
sion levels of mitochondrial transcription
factor A (TFAM) (Figure 4C) were
increased in the KO versus WT and AOX
but were similar to WT values in the dou-
ble recombinant KO-AOX animals. In
addition, the amount of several subunits
of the respiratory complexes was signifi-
cantly increased in KO versus WT andAOX, but not in samples from KO-AOX mice (Figure 4D). Overall,
these data suggest that AOX expression blunts the increased
mitochondrial biogenesis observed in the muscle-specific
Cox15-defective model.
We then investigated whether the main mitochondriogenic
control pathways were affected by AOX in KO muscles. AMP-
dependent kinase (AMPK) is an important sensor of cellular en-
ergetic status and is activated when the AMP/ATP ratio in-
creases (Lin and Hardie, 2017). Under such energy-deficient
conditions, AMPK is activated by phosphorylation of Thr172
(p-AMPK) by LK1 kinase and, in turn, p-AMPK phosphorylates
a large number of targets, including the transcriptional co-acti-
vator PGC-1a, a master regulator of mitochondrial biogenesis.
As previously reported (Viscomi et al., 2011), p-AMPK was upre-
gulated in KOmice, but it waswithin the normal range in KO-AOX
animals (Figure 4E). Moreover, PGC-1a protein amount was also
increased in KO versus WT and AOX, while it was normal in KO-
AOX muscle samples (Figure 4F). Finally, quantitative transcript
Figure 3. AOX Impairs the Regeneration Ca-
pacity of Myofibers
(A) Representative confocal 3D z stack image of
8-week-old muscle fibers labeled with PAX7 (red),
MYOD (green), and DAPI (blue). The image repre-
sents a randomly chosen image from four samples.
Scale bar, 50 mm.
(B) Quantification of the number of positive PAX7,
PAX7/MYOD, and MYOD nuclei in muscles of WT,
AOX, KO, and KO-AOX animals (n = 4). Bars
represent means ± SEM. Asterisks over the bars
indicate statistical significance versus WT; over the
brackets among indicated groups. *p % 0.05;
**p% 0.01; unpaired Student’s t test.analysis showed decreased expression of several genes related
to the respiratory chain in KO-AOX versus KO mice, confirming
that mitochondrial biogenesis is diminished in the presence of
AOX (Figure 4G).
AOX Impairs ROS Signaling in KO Mice
Since AOX prevents excessive ROS production, we reasoned
that it might interfere with ROS signaling in cIV-deficient muscle.
Thus, we quantified ROS production in skeletal muscle mito-
chondria by measuring hydrogen peroxide (H2O2) production.
Succinate-driven H2O2 production was significantly increased
in KO compared with WT and AOX mitochondria but was lower
in KO-AOX double mutants than in WT animals (Figure 5A).
Accordingly, mitochondrial aconitase (ACO2) activity, which is
inhibited by H2O2, was significantly lower in the KO compared
with WT and AOX mitochondria but had normal values in theCell MetabKO-AOX samples (Figure 5B). Altogether,
these results are consistent with AOX be-
ing active only under stress conditions, as
previously reported (Szibor et al., 2016).
Since AOX requires a highly reduced
CoQ pool to be activated (Dry et al.,
1989), we measured the amount of
reduced and oxidized CoQ in frozen skel-
etal muscle of the mice. The relative
amount of reduced CoQ was increased
in KO versus WT and AOX mice but was
comparable with WT in the double mu-
tants, confirming that AOX efficiently oxi-
dizes the CoQ pool (Figure 5C). These re-
sults support the idea that RET, which is
promoted by over-reduction of the CoQ
pool, is involved in generating ROS in the
KO model, and that this phenomenon is
blunted by AOX.
Increased ROS can trigger the oxidative
stress response via KEAP1/NFE2L2
signaling. Accordingly, the transcripts for
superoxide dismutase (Sod2) and gluta-
thione peroxidase (Gpx1), two key en-
zymes of the antioxidant response that
are NFE2L2 targets, were significantly
increased in KO versus WT and AOX
mice, but significantly decreased in KO-AOX versus KO animals (Figure 5D). A similar trendwas detected
for both Cat, encoding catalase, and Sod1, encoding the cyto-
solic isoform of superoxide dismutase (Figure 5D). A significant
increase of the Nfe2l2 transcript was also detected in KO but
not in KO-AOX samples (Figure 5D).
Various retrograde signals frommitochondria can be activated
under stress conditions associated with increased ROS, energy
deficiency, and loss of Dj (Quiro´s et al., 2016). As low levels of
ATP can activate AMPK, as well as ROS (Rabinovitch et al.,
2017), we assessed the ATP production rate. We found a strong
but comparable impairment of ATP synthesis in both KO and
KO-AOX skeletal muscle mitochondria, using either cI- or cII-
linked substrates (Figure 5E). In addition, the ATP content was
comparably lower than controls in KO and KO-AOX samples
(Figure 5F). Likewise, Dj was markedly but comparably lower
than controls in both KO and KO-AOX muscle mitochondriaolism 28, 764–775, November 6, 2018 767
Figure 4. AOX Interferes with Mitochondrial Biogenesis in KO-AOX Mice
(A) Spectrophotometric activity of citrate synthase (CS)-specific activity (n = 5).
(B) mtDNA copy number by qPCR (n = 8–10).
(C) Western blot and quantification (n = 5) of TFAM.
(legend continued on next page)
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(Figure 5G). The comparable decrease of ATP production rate,
ATP steady-state levels, and Dj in KO and KO-AOX indicates
that impaired bioenergetics is not the main reason for the more
severe phenotype of KO-AOX mice.
To further test the hypothesis that decreased ROS production
underlies the aggravated phenotype, we supplemented the
drinking water of eight KO mice after weaning with N-acetylcys-
teine (NAC), a cell-permeable precursor of glutathione (Viscomi
et al., 2010). The mean survival was significantly shorter in
treated versus untreated animals, and the maximal lifespan
was grossly decreased in the NAC-treated cohort, although
NAC supplementation also delayed the earliest deaths of KO
mice (Figure 1A).
Autophagy Is Restored in KO-AOX Skeletal Muscle
Mitochondrial biogenesis and autophagy together regulate mito-
chondrial content (Peralta et al., 2016).Wemeasured the amount
of LC3, a marker for autophagosomes, and P62, a marker for au-
tophagic cargoes, in skeletal muscle samples of the different
models. The ratio between lipidated, autophagosome-associ-
ated LC3 (LC3-II) and non-lipidated, cytosolic free LC3 (LC3-I)
was significantly decreased, whereas the amount of P62 was
increased, in KO versus WT and AOX muscles, suggesting
decreased autophagy (Figure 6A). Conversely, KO-AOX muscle
showed a markedly increased LC3-II/LC3-I ratio while the levels
of P62 were comparable with WT, indicating no decrease in
autophagy.
Mitochondrial Stress Markers Are Comparably
Increased in Both KO and KO-AOX
A number of mitochondrial pathways are activated in response to
mitochondrial dysfunction. We measured the expression at the
protein and/or mRNA level, of several components of this
integrated stress response, including (1) key players of the
mitochondrial unfolded protein response (UPRmt) (Shpilka
and Haynes, 2017), such as the bZIP transcription factors Chop
(C/EBP-homologous protein), Atf4, and Atf5 (Fiorese et al.,
2016), and mitochondrial chaperones HSP60/HSPD1 and
mtHSP70/HSPA9 (Dogan et al., 2014); (2) components of the
one-carbon/mitochondrial folate cycle, e.g., methylene tetrahy-
drofolate dehydrogenase 2 (MTHFD2) (Khan et al., 2017; Kuhl
et al., 2016), and enzymes of proline biosynthesis from glutamate,
e.g., delta-1-pyrroline-5-carboxylate synthase (ALDH18A1) and
mitochondrial pyrroline-5-carboxylate reductase 1 (PYCR1); and
(3) the fibroblast growth factor 21 (Fgf21) and growth differentia-
tion factor 15 (Gdf15) mitokines (Lehtonen et al., 2016). Increased
amounts of these markers or their transcripts were detected in
both KO and KO-AOX animals (Figures 6B–6D). In particular,
Fgf21 mRNA was highly expressed in KO muscles, and even
more so (260-fold) in KO-AOXmice (Figure 6D).Gdf15was about
100-fold higher than controls in KOmice, but significantly lower in(D) Western blot and quantification (n = 5) for MRC complexes. Individual subun
(E) Representative western blot for phosphorylated and total AMPK.
(F) Western blot and quantification (n = 5) of PGC-1a.
(G) Relative expression levels of respiratory chain transcripts (n = 6). Results rep
All experiments were performed on 8-week-old mice with western blots using ske
Bars represent means ± SEM. Asterisks over the bars indicate statistical signific
0.01; ***p% 0.001; unpaired Student’s t test.KO-AOX, although still increased relative to WT animals (Fig-
ure 6D). Other factors involved in the integrated stress response,
including Atf3 and Atf6, related respectively to cell death and ER-
stress pathways, did not change (Atf3) or changed to a very small
extent (Atf6). Interestingly, the activation of these stress-related
pathways in our KO model takes place via EIF-2alpha and not
via mTORC1 (Melber and Haynes, 2018). The levels of mTORC1
target eukaryotic translation initiation factor-binding protein 1
(EIF4EBP1), an important player in protein synthesis (Morita
et al., 2013) was increased in both KO and KO-AOX compared
with WT. However, phosphorylated versus unphosphorylated
EIF4EBP1 ratio was decreased to the same extent in KO and
KO-AOX versus WT and AOX mice, indicating that mTORC1
signaling, and thus protein synthesis and cell growth, was
reduced in both KO and KO-AOX muscles. In contrast, we de-
tected increased levels of phosphorylated EIF-2alpha in both
KO and KO-AOX mice compared with both WT and AOX litter-
mates (Figures S5A–S5C). These findings suggest that the induc-
tion ofmajor mitochondrial stress responses correlateswithmito-
chondrial myopathy and disease progression but AOX did not
significantly modify these pathways, except insofar as it wors-
ened the myopathy, affecting the expression of relevant endo-
crine markers, such as Gdf15 (Figure 6E).
DISCUSSION
While the expression of an AOX xenogene on a murine WT
background had hardly any consequences, we here showed
that AOX entrains a dramatic worsening of the clinical and
biochemical phenotype in a mouse model of COX-defective
mitochondrial myopathy. Under stress conditions, including de-
fects of cIII or cIV, AOX directly oxidizes CoQ, maintaining elec-
tron flow from NADH and FADH2 but abolishing the contribution
of cIII and cIV to the formation of the Dj. The unexpected
outcome observed in the KO-AOX double mutant model sug-
gested two possible mechanisms: a direct bioenergetic failure
caused by the exclusion of the proton pumping activity of cIII
and cIV, or an indirect effect consequent to decreased ROS
signaling and blunting of mitochondrial biogenesis. We
excluded the first possibility, since no difference was detected
in the ATP production rate, ATP levels, or Dj between KO and
KO-AOX muscle samples, as expected since AOX does not
translocate protons across the mitochondrial inner membrane.
Conversely, ROS production was significantly decreased in
KO-AOX muscle as were several indicators of mitochondrial
biogenesis.
Redox signaling controls a large number of transcriptional
pathways (Holmstro¨m and Finkel, 2014). However, its impor-
tance in vivo has not been adequately investigated. While our
results argue against the general applicability of AOX as a thera-
peutic tool in mitochondrial disorders, they provide solid geneticits and the complexes are indicated on the left.
resent fold increase normalized against WT.
letal muscle homogenates of 8-week-old mice and GAPDH as loading control.
ance versus WT; over the brackets among indicated groups. *p% 0.05; **p%
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Figure 5. AOX Impairs ROS Signaling in KO Mice
(A) H2O2 production rate caused by RET in isolated skeletal muscle mitochondria (n = 4).
(B) Aconitase2 activity in frozen skeletal muscle samples (n = 5).
(C) Percentage of reduced CoQ in frozen muscle samples.
(D) Relative expression levels of antioxidant response transcripts (n = 6). Results represent fold increase normalized against WT.
(legend continued on next page)
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evidence in a mammalian mitochondrial disease model of the
crucial pathophysiological role of ROS-dependent pathways as
compensatory responses to mitochondrial dysfunction, at least
in skeletal muscle, as previously suggested (Horn et al., 2017;
Reczek and Chandel, 2015). This has obvious implications in
understanding some of the pathogenic mechanisms of mito-
chondrial diseases and can potentially be exploited to develop
effective therapies. For instance, an ROS-based mechanism
can underpin the formation of ragged-red fibers (RRFs), a
morphological hallmark of mitochondrial myopathy. RRFs are
determined by the segmental accumulation of dysfunctional
mitochondria along the muscle syncytium, especially in the
sub-sarcolemmal region. However, the mechanism leading to
their formation is poorly understood. We propose that ROS
can be a major signal inducing the local proliferation of mito-
chondria, in an attempt to compensate their functional defect
through the activation of a mitochondriogenic program by the
surrounding nuclei. Furthermore, our findings support the idea
that the induction of mitochondrial biogenesis, for instance by
activating the SIRT1-and/or AMPK-dependent PGC-1a axis, or
other mitochondriogenic pathways, could be a rational and
potentially effective approach in the therapy of mitochondrial
diseases. Interestingly, there is increasing evidence that AMPK
is directly regulated by ROS either through oxidation and S-glu-
tathionylation of cysteines 299 and 304 in the a subunit, leading
to the activation of the enzyme, or oxidation of cysteines 130 and
174 in the a subunit, resulting in its inactivation (Shao et al.,
2014). An additional mechanism potentially contributing to the
decrease of mitochondrial content is the maintenance of auto-
phagic flux in KO-AOX, as suggested by an increased LC3-II/
LC3-I ratio and normalization of the P62 level, which is impaired
in KOmuscle. Further investigation will be needed to understand
whether this effect is directly related to decreased ROS produc-
tion or is an indirect consequence of the activation of stress re-
sponses. The integrated stress response is indeed activated in
both KO and KO-AOX mice. This seems to be controlled by
the activation of the translation initiation factor EIF-2alpha by
phosphorylation operated by GCN2 or other kinases under mito-
chondrial stress conditions (Melber and Haynes, 2018) and as
observed in other mouse models of mitochondrial dysfunction
(Seiferling et al., 2016). In contrast, mTORC1 signaling, which
was shown to regulate mitochondrial integrated stress response
in a model of impaired mtDNA replication (Khan et al., 2017), is
inhibited in both KO and KO-AOX mice as indicated by reduced
levels of phosphorylated EIF4EBP1. Interestingly, we found that
two mitokines recently introduced as biomarkers for mitochon-
drial myopathies (Lehtonen et al., 2016) were both highly
increased in KO and KO-AOX mice. However, while Fgf21 was
much higher in KO-AOX than in KO, Gdf15 was reduced in
KO-AOX compared with KO, implying a stress-dependent
modulation of the latter, as suggested by previous work (Chung
et al., 2017).(E) ATP synthesis flux in skeletal muscle mitochondria in the presence of cI-li
(succinate, rotenone) + ADP (n = 4).
(F) ATP content in frozen skeletal muscle samples (n = 6–8).
(G) Analysis of mitochondrial membrane potential using safranin in isolated skele
All experiments were performed on 8-week-old mice. Bars represent means ± SE
brackets among indicated groups. *p% 0.05; **p% 0.01; ***p% 0.001; ****p < 0An intriguing finding of our study is the decrease in the number
of centralized nuclei in KO-AOX versus KO muscle fibers.
Centralized nuclei are a primary sign of muscle regeneration
(Yin et al., 2013). During muscle regeneration, satellite cells,
which constitute the resident pool of stem cells in skeletal mus-
cle, undergo a process of activation, characterized by prolifera-
tion and migration to the site of damage, where they differentiate
into myocytes and eventually fuse with the existing myofibers.
Specific transcription factors are expressed during this process,
including Pax7, MyoD, and Myogenin. Our data suggest that
ROS influence this pathway, similar to what is observed in other
populations of stem cells. Myogenic differentiation is associated
with high ROS levels, mainly due to the concomitant induction of
mitochondrial biogenesis (L’honore´ et al., 2014). Antioxidant de-
fenses are activated at the same time to prevent cellular damage
(Latella and Puri, 2014). The decreased number of centralized
nuclei and reduced PAX7- and MYOD-positive nuclei in KO-
AOX muscles indicate that satellite cells are present but cannot
differentiate into myotubes, thus impairing the capacity for
repair/regeneration of the myofibers. This effect is likely to
have an important role in the observed worsening of the pheno-
type in KO-AOX mice.
The majority of ongoing clinical trials for mitochondrial dis-
eases are based on the use of antioxidants, stemming from the
assumption that excessive ROS production causes oxidative
damage to cellular components. However, there has hitherto
been only a minimal investigation of the extent of ROS produc-
tion and oxidative damage in mitochondrial diseases in vivo,
and the available data are contradictory. For instance, in the mu-
tator mouse (Trifunovic et al., 2004), no signs of oxidative dam-
age have been detected in post-mitotic tissues (Trifunovic
et al., 2005), while extensive ROS damage has been shown in
replicating cells (Hamalainen et al., 2015). Our data using both
AOX and NAC highlight a potential risk associated with antioxi-
dant use, of interfering with compensatory ROS signaling, at
least in mitochondrial myopathies. This observation is in agree-
ment with previous reports showing that antioxidants can have
deleterious effects on pluripotent stem cells with impaired mito-
chondrial function (Hamalainen et al., 2015). However, it should
be noted that NAC and AOX act on redox homeostasis through
different mechanisms, as AOX prevents excess ROS production
by increasing electron flow along the respiratory chain and is ex-
pressed transgenically throughout embryonic development,
while NAC, a glutathione precursor, was administered shortly af-
ter weaning, thus explaining the observed differences in their
survival curves.
In our model, COX deficiency leads to accumulation of the
reduced form of CoQ, and thus to excess production of superox-
ide anion via RET. By re-activating the electron flow along the
respiratory chain, AOX normalizes the CoQ pool and abolishes
the increases in RET and ROS production. Our data indicate
that this effect, in turn, precludes the activation of a number ofnked substrates (pyruvate, malate, glutamate) + ADP or cII-linked substrate
tal muscle mitochondria (n = 4).
M. Asterisks over the bars indicate statistical significance versus WT; over the
.0001; unpaired Student’s t test.
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Figure 6. Mitochondrial Stress Responses Are Upregulated Regardless of AOX Expression, Except for Autophagy
(A) Western blots and quantification (n = 10) of autophagy markers (P62, LC3-I, and -II).
(B) Western blots and quantification (n = 10) of proteins involved in UPRmt (HSP60 and mtHSP70) and mitochondrial metabolism (MTHFD2, PYCR1, and
ALDH18A1). *Unspecific protein.
(legend continued on next page)
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transcriptional response pathways and networks, as confirmed
by real-time PCR data. Thus, AOX (or antioxidants) can block
the homeostatic response to bioenergetic failure, exacerbating
the pathological phenotype.
Our data do not rule out the possibility that AOX may be bene-
ficial in other conditions affecting different organs and/or due to
different mutations, which impair the activities of cIII and/or cIV
or affect multiple respiratory complexes. It is also worth noting
that not all mitochondrial diseases are associated with increased
mitochondrial biogenesis. In addition, ROS produced at different
sites may have different impact on whether their signaling or
toxic role prevails (Sanz, 2016). In particular, it has recently
been shown that ROS produced selectively via RET increases
lifespan in Drosophila, whereas an opposite effect is observed
when RET is prevented by increasing CoQ oxidation via AOX
expression (Scialo` et al., 2016), suggesting that over-reduction
of CoQ generates an ROS signal important for homeostasis via
RET. Along the same lines, we showed here that the accumula-
tion of over-reduced CoQ increases ROS production via RET,
triggering complex transcriptional cascades, which control mito-
chondria-related pathways to alleviate the pathology. Our find-
ings thus have important consequences for the future treatment
of mitochondrial disorders.Limitations of the Study
Our work is limited to a single antioxidant compound in a single
COX-defective myopathy. Antioxidants are widely used in the
therapy of mitochondrial diseases and, although there is weak
evidence of their efficacy, toxicity is usually not a major concern.
We cannot exclude that in conditions associated with cIII or cIV
deficiency in which ROS overproduction plays a major patho-
genic role, the introduction of AOX may be beneficial.STAR+METHODS
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Rabbit polyclonal anti-HSP60 Abcam Cat#ab46798; RRID: AB_881444
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Rabbit polyclonal anti-PAX7 Thermo Fisher Scientific Cat#PA1-117; RRID: AB_2539886
Rabbit polyclonal anti-PGC-1a Santa Cruz Biotechnology Cat#sc-13067; RRID: AB_2166218
Rabbit monoclonal anti-phospho-EIF4EBP1 (Thr37/Thr46) Cell Signaling Cat#2855; RRID: AB_560835
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Rabbit monoclonal anti-phospho-EIF2a (Ser51) (D9G8) Cell Signaling Cat#3398; RRID: AB_2096481
Rabbit polyclonal anti-PYCR1 Proteintech Cat#13108-1-AP; RRID: AB_2174878
Rabbit polyclonal anti-TFAM Abcam Cat#ab131607; RRID: AB_11154693
Mouse monoclonal anti-total OXPHOS antibody cocktail Abcam Cat#ab110412
Chemicals, Peptides, and Recombinant Proteins
N-acetyl-L-cysteine Sigma-Aldrich Cat#A7250
Hematoxylin solution according to Mayer Sigma-Aldrich Cat#51275-1L
Eosin Y Sigma-Aldrich Cat#E4009-25G
DAKO Antibody diluent Agilent Dako Cat# S3022
Prolong Diamond Antifade with DAPI Invitrogen Cat#P36962
TRIzol reagent Invitrogen Cat#15596026
DNA-free DNA removal kit Ambion Cat#AM1906
Omniscript reverse transcription kit Qiagen Cat#205113
TaqMan Assay-on-Demand Fgf21 Thermo Fisher Cat#Mm00840165_g1
TaqMan Assay-on-Demand Gdf15 Thermo Fisher Cat#Mm00442228_m1
TaqMan Assay-on-Demand Gapdh Thermo Fisher Cat#Mm99999915_g1
TaqMan Assay-on-Demand Hprt Thermo Fisher Cat#Mm00446968_m1
PowerSYBR Green PCR master mix Applied Biosystems Cat#4367659
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L-Glutamic acid, monosodium salt hydrate Sigma-Aldrich Cat#G1626
L-Malic acid Sigma-Aldrich Cat#M1000
Pyruvic acid, sodium salt Sigma-Aldrich Cat#P2256
ADP Sigma-Aldrich Cat#A5285
KCN Fluka Cat#60178
Oligomycin Sigma-Aldrich Cat#O4876
Rotenone Sigma-Aldrich Cat#R8875
Safranin Sigma-Aldrich Cat#S2255
Cytochrome c Sigma-Aldrich Cat#C7752
DTNB Sigma-Aldrich Cat#D8130
Acetyl-Coenzyme A Sigma-Aldrich Cat#A2181
Oxaloacetate Sigma-Aldrich Cat#O4126
Critical Commercial Assays
Aconitase activity assay kit Sigma-Aldrich Cat#MAK051
ATP determination kit Molecular Probes Cat#A22066
Experimental Models: Organisms/Strains
Mouse: COX15sm/sm (KO): Tg/ACTA/BL6 Viscomi et al., 2011 N/A
Mouse: AOX: Tg/CAG/BL6 Szibor et al., 2016 N/A
Oligonucleotides
See Table S1 for primer sequences This paper N/A
Software and Algorithms
GraphPad Prism 7 for Mac OS X GraphPad Software Version 7.0d
Fiji Schindelin et al., 2012 RRID: SCR_002285
Zen Pro Carl Zeiss Ltd. 14.0.9.201
Fusion Andor Technologies 1.5.0.7
Imaris Bitplane 9.1.2
Other
Pre-cast NuPAGE 4%–12% Bis-Tris gels Invitrogen Cat#NP0322BOXCONTACT FOR REAGENT AND RESOURCE SHARING
More information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Carlo Vis-
comi (cvf23@mrc-mbu.cam.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All procedures were conducted under the UK Animals (Scientific Procedures) Act, 1986, approved by Home Office license (PPL: 70/
7538) and local ethical review. The animals were maintained on a C57BL/6-129Sv mixed background at 19-21C in a temperature-
and humidity-controlled animal-care facility, with a 12 hr light/dark cycle and free access to water and food (R105, Safe Diets, Augy,
France), and were sacrificed by cervical dislocation. All the experiments were performed using 8-week-old mice. Both males and
females were used in the experiments as no gender-related differences were observed.
AOX mice were knocked-in in the ROSA26 locus and under the ubiquitous, early onset CMV immediate enhancer/chicken beta
actin (CAG) promoter (Szibor et al., 2016).
Cox15sm/sm mice were supplemented with N-acetyl-L-cysteine (Sigma-Aldrich, A7250) in the drinking water (1%, pH 7.0), which
was changed twice per week. Animals were checked and weighed weekly and any that lost 20% of their pre-study weight or showed
clinical signs reaching the moderate end point were culled.
Total movement of mice during night was counted using the Comprehensive Lab Animal Monitoring System (CLAMS, Columbus
Instruments).Cell Metabolism 28, 764–775.e1–e5, November 6, 2018 e2
METHOD DETAILS
Histochemistry, Immunofluorescence and Imaging
For histochemical analysis, skeletal muscles were frozen in isopentane pre-cooled with liquid nitrogen. 8 mm thick sections were
stained for COX and SDH activity. For SDH analysis six images per sample were acquired randomly in places of mixed intensity fibers
keeping the same light intensity and exposure settings using an Axio Observer Z1 with ApoTome 2 (Carl Zeiss Ltd.), composed by a
Zeiss 10x ApoPlan objective and an AxioCam ICc1 camera. Images were acquired using Zen Pro software and analysed with Fiji
(% of total area) (Schindelin et al., 2012) keeping the same threshold for all samples.
Analysis of cross sectional area and centralized nuclei was performed on hematoxylin and eosin (H & E)-stained sections using Fiji
on four samples/genotype (600 fibers/sample).
For immunofluorescence, slides were fixed in 4% PFA for 10 min, washed in PBS and then incubated in 0.2% triton in PBS for
15 min. After washing in PBS, sections were incubated in blocking solution (5% normal goat serum, 2% BSA, 1:40 M.O.M. blocking
reagent in PBS) for 1 h at RT and then incubated with primary antibodies diluted in DAKO Antibody diluent with background reducing
components for 1 h at RT. Slides were washed in PBS for 15 min and incubated for 1 h at RT with Alexa Fluor secondary antibodies
(1:300 in DAKO Antibody diluent with background reducing components). Sections were washed in PBS and mounted with Prolong
Diamond Antifade with DAPI (Invitrogen).
For PAX7/MYOD analysis five images were acquired randomly for each slide using a Dragonfly Spinning Disk imaging system
(Andor Technologies Ltd.), composed by a Nikon Ti-E microscope, Nikon 20x ApoPlan objective and an Andor Ixon EMCCD
camera. The z-stacks were acquired using Fusion software (Andor Technologies) and the 3D images analysed using Imaris soft-
ware (Bitplane) creating spots surfaces for each channel (MYOD and PAX7) keeping the same conditions for all the samples. A
surface was created using the autofluorescence of the tissue to measure the area and the number of positive nuclei was normal-
ized per area.
Fiber typing analysis was calculated from entire muscle sections using a Tile image acquired using the Dragonfly Spinning Disk as
previously described for MYOD/PAX7. The morphometric analysis was performed using Imaris software creating surfaces for each
channel.
No blinding was used for any of the histological/immunofluorescence analysis. No samples were excluded from analysis.
Analysis of Mitochondrial Enzyme Activities
Skeletal muscle samples were snap-frozen in liquid nitrogen and homogenized in 10mMphosphate buffer (pH 7.4). The spectropho-
tometric activities of cIV and citrate synthase (CS) weremeasured as described (Bugiani et al., 2004). In brief, complex IV activity was
measured by following reduction of cytochrome c at 550 nm at 37C. 10 mg mitochondria were incubated in a mix containing 10 mM
KH2PO4, pH 7.2 and between 5 and 50 m M cytochrome c.
Citrate synthase activity was measured at 30C by incubating 10 mg mitochondria in a reaction mixture containing 125 mM Tris–
HCl, 100 mMDTNB (5,50-dithiobis(2-nitrobenzoic acid)) and 300 mM acetyl coenzyme A. The reaction was initiated by the addition of
500 m M oxaloacetate, and DTNB reduction at 412 nm measured for 2 min.
Analysis of Body Composition
Nuclear magnetic resonance (NMR) was employed to determine the body fat content of live animals using the NMR Analyzer Min-
ispec mq7.5 (Bruker Optik, Ettlingen, Germany).
Real-Time Quantitative Polymerase Chain Reaction
RNA was isolated from skeletal muscles using TRIzol reagent (Invitrogen, 15596026) according to manufacturer’s instructions,
treated with DNAse (DNA-free Kit, Ambion) and subsequently reversely transcribed with the Omniscript reverse transcription kit
(Qiagen, 205113). Fgf21 (Mm00840165_g1), Gdf15 (Mm00442228_m1), Gapdh (Mm99999915_g1) and Hprt (Mm00446968_m1)
probes were obtained from TaqMan Assay-on-Demand kits (Applied Biosystems).
All the other transcripts, including mtDNA content, were analyzed by SYBR Green real-time PCR. Samples were adjusted for total
RNA content by Hprt, Gapdh or in the case of mtDNA content, RNaseP. Relative expression of mRNAs was determined using a
comparative method (2DDCT). Primer sequences are provided in Table S1.
Western Blot Analysis
Proteins, extracted from homogenized skeletal muscle samples, were separated by denaturing NuPAGE 4%–12% Bis-Tris gels.
The primary antibodies were used in dilutions recommended by the suppliers. The list of antibodies is included in the Key Resources
Table.
Mitochondria Isolation and H2O2 Production
Mitochondria were isolated from skeletal muscle as described (Frezza et al., 2007). Briefly, small pieces of skeletal muscles were
incubated in ice-cold PBS/10 mM EDTA and 0.05% trypsin for 30 minutes on ice. After centrifugation at 200 g for 5 min at 4C,e3 Cell Metabolism 28, 764–775.e1–e5, November 6, 2018
the pellet was resuspended in IBM1 buffer (67 mM Sucrose, 50 mM KCl, 50 mM Tris-HCl pH 8, 10 mM EDTA, 0,2% BSA free from
fatty acids, pH 7.4). The pieces were homogenized by hand, centrifuged at 700 g for 10 minutes at 4C. The supernatant was further
centrifuged at 8000 g for 10 minutes at 4C to pellet mitochondria, which was resuspended in IBM2 buffer (250 mM sucrose, 0.3 mM
EGTA-Tris, 10 mM Tris-HCl, pH 7.4).
H2O2 production rate was measured at 37
C using 130 mg of mitochondria diluted in 2 ml of mitochondrial respiration buffer
(120 mM sucrose, 50 mM KCl, 20 mM Tris–HCl, 4 mM KH2PO4, 2 mM MgCl2, 1 mM EGTA, 1 mg/ml fatty-acid-free BSA, pH 7.2)
in an Oxygraph-2k using O2k-Fluo LED2-Module (OROBOROS INSTRUMENTS, Innsbruck, Austria). The rationale behind the
method is monitoring the oxidation of the fluorogenic indicator Amplex Red Reagent (Life Technologies, A12222) in the presence
of horseradish peroxidase (Sigma-Aldrich, P8250) and superoxide dismutase (Sigma-Aldrich, S8409) (Krumschnabel et al., 2015).
The final concentrations of Amplex Red, horseradish peroxidase and superoxide dismutase in the incubation medium were
10 mM, 4 U/ml and 5 U/ml, respectively. H2O2 production rate measurements were initiated by succinate (final concentration
10 mM) addition as a substrate for cII. In a separate experiment, a standard curve was obtained by adding known amounts of
H2O2 to the assay medium in the presence of the reactants. The H2O2 production rate was determined from the slope of a plot of
the fluorogenic indicator versus time.
For (cyanide-resistant) respiration, after addition of cI-linked or cII-linked substrates, including 1 mM ADP, 1 mM KCN or 2.5 mg/ml
oligomycin was added into the Oxygraph-2k chambers.
Mitochondrial Aconitase Activity
Mitochondrial aconitase 2 activity was measured by Aconitase Activity Assay Kit (Sigma-Aldrich, MAK051) according to the manu-
facturer’s protocol.
QH2/Q Measurements
In order to measure the proportion of both reduced and oxidized CoQ, a rapid lipid extraction was performed. Briefly, 10 to
15 mg of muscle tissue was homogenized with a manual micropestle in 20 mM potassium phosphate buffer pH 7.5, and debris
were discarded by maximum speed centrifugation, at 4C. 100 ml of sample was mixed by vortex with 330 ml of n-propanol in
the presence of 0.5 mM b-mercaptoethanol. Sample debris were discarded after spin at maximum speed and clean lipid
extracts were immediately injected into a reverse-phase Beckmann 166 HPLC system, equipped with a C18 column (5 mm,
150 x 4.6 mm) and column oven set up at 40C. Mobile phase, flow rate and gradient settings were as described previously
(Rodrı´guez-Aguilera et al., 2017). CoQ detection was performed by a Coulochem III ESA electrochemical detector linked to the
HPLC system and conditioning cell was set up before injection valve in order to maintain the oxidation state of the sample
analytes.
Measurement of ATP Synthesis Flux and ATP Content
ATP production rate was assessed as described (Mourier et al., 2015). Briefly, isolated skeletal muscle mitochondria (65 mg/ml) were
suspended in the mitochondrial respiration buffer (see ‘‘Measurement of H2O2 production’’). After addition of ADP (1 mM), succinate
(2 mM) and rotenone (10 nM) or addition of ADP (1 mM), pyruvate (10 mM), glutamate (5 mM) and malate (5 mM), aliquots were
collected every 20 seconds and precipitated in 7%HClO4/25 mMEDTA, centrifuged at 16,000 gmax for 10 minutes, and then neutral-
ized with 2 M KOH and 0.3 M MOPS. The ATP content in these samples was determined with ATP determination kit (Molecular
Probes, A22066) according to the manufacturer’s instructions. In a parallel experiment, oligomycin (2.5 mg/ml protein) was added
to the mitochondrial suspension to determine the nonoxidative ATP synthesis rate.
ATP content in frozen skeletal muscle samples was measured as described (Fernandez-Marcos et al., 2012) using the same kit as
above. Briefly, tissues were weighed and lysed in 600 ml of 6% (v/v) perchloric acid, and centrifuged at 4,000 gmax for 10 minutes at
4C. 500 ml of the supernatant were neutralizedwith 200 ml of 2.5MKOH, and precipitate was removed by centrifugation at 4,000 gmax
for 5 minutes at 4C. Luciferase activity was measured with a lag time of 1 second and an integration time of 3 seconds using a
GloMax 96 Microplate Luminometer (Promega).
Mitochondrial Membrane Potential Measurement
Mitochondrial membrane potential was assessed as described (Chowdhury et al., 2015). In brief, Oxygraph-2k was used with O2k-
Fluorescence LED2 module equipped with filter sets for safranin (excitation at 495 nm and emission at 587 nm). Safranin (Sigma-
Aldrich, S2255) dissolved in distilled water up to a final concentration of 2.5 mM. Isolated skeletal muscle mitochondria (65 mg/ml)
were suspended in the mitochondrial respiration buffer (see ‘‘Measurement of H2O2 production’’) including 2.5 mM safranin. The
membrane potential was tracked live with the addition of ADP (2.5 mM), pyruvate (5 mM), glutamate (10 mM) and malate (5 mM)
or ADP (2.5 mM), succinate (10 mM) and rotenone (0.5 mM). In a separate experiment, a standard curve was obtained by adding
known amounts of safranin to the assay medium in the presence of mitochondria. The signal was then normalized (0–1) to detect
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QUANTIFICATION AND STATISTICAL ANALYSIS
Fiji software (Schindelin et al., 2012) was used for quantification. Statistical analyseswere performed usingGraphPad Prism 7 forMac
OS X (GraphPad Software; La Jolla, CA, USA).
Unpaired Student’s t-test was used for pairwise comparisons of independent experimental groups. Kaplan–Meier distribution and
one sample t-test were used for survival analysis. No particular method was used to determine whether the data met assumptions of
the statistical approach. Grubb’s test was used to determine outliers. Error bars represent standard error of the mean (S.E.M.).e5 Cell Metabolism 28, 764–775.e1–e5, November 6, 2018
